{"id":"W4398255869","doi":"10.1017/cjn.2024.119","title":"P.011 Efficacy and safety of ravulizumab in adults with AQP4+ NMOSD: interim analysis from the ongoing phase 3 CHAMPION-NMOSD trial","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Burnaby Hospital","funders":"","keywords":"Adverse effect; Medicine; Interim; Incidence (geometry); Interim analysis; Clinical trial; Pediatrics; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002916009,0.0004335505,0.0009319524,0.0001576033,0.0003207209,0.0008800828,0.0003669836,0.0005927275,0.009185392],"category_scores_gemma":[0.002136034,0.0001796362,0.001266135,0.0002820072,0.0002787452,0.0005683348,0.000258334,0.001762107,0.001436391],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003603151,"about_ca_system_score_gemma":0.0007990153,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003035181,"about_ca_topic_score_gemma":0.0006373221,"domain_scores_codex":[0.9992638,0.0003268018,0.00005941595,0.00009565888,0.0001294982,0.0001248118],"domain_scores_gemma":[0.99876,0.000432207,0.0003384585,0.0001051193,0.0001643147,0.0001998847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6458747,0.005953456,0.05852658,0.001381926,0.004841167,0.0004282363,0.0001964989,0.002150408,0.01178765,0.0004681963,0.03274476,0.2356464],"study_design_scores_gemma":[0.3895151,0.2527588,0.2939206,0.0004331504,0.006922849,0.001403512,0.000153913,0.005579385,0.007708452,0.001702577,0.03982154,0.00008023877],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9616321,0.008898235,0.001861375,0.002555215,0.0004326884,0.00151524,0.008514551,0.0002200479,0.01437066],"genre_scores_gemma":[0.9856609,0.0009468016,0.002025457,0.001064298,0.000318459,0.001303164,0.005067603,0.00004441365,0.003568979],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009185392,"threshold_uncertainty_score":0.03072822,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03587940407397829,"score_gpt":0.3184863549021765,"score_spread":0.2826069508281982,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}